Fundraising FoxAiolos Bio
5 known investors
Find your way into Aiolos Bio
Sign up to see every warm intro you have to Aiolos Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aiolos Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aiolos Bio is a biopharma company that discovers, develops, and delivers medicines and vaccines across respiratory, immunology, inflammation, oncology, HIV, and infectious diseases.
Investors · 5
Bain Capital Life Scienceslisted by Bain Capital Life SciencesBoston
How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us
Sofinnova Ventureslisted by Sofinnova VenturesMenlo Park · $100K – $15M
How we know: Sofinnova Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- AIOLOS BIO LIMITED
- Company number
- 14956089
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 23 Jun 2023
- Registered office
- 79 New Oxford Street, London, WC1A 1DG
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Previous names
- ONE BIOTECH LIMITED (2023–2023)
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 16 Apr 2026 · next due 30 Apr 2027
Current officers · 2
- Peter Kenneth Hopkins — director, appointed 14 Feb 2024
- Edinburgh Pharmaceutical Industries Limited — corporate director, appointed 14 Feb 2024
Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Aiolos Bio do?
- Aiolos Bio is a biopharma company that discovers, develops, and delivers medicines and vaccines across respiratory, immunology, inflammation, oncology, HIV, and infectious diseases.
- Who are Aiolos Bio's investors?
- Aiolos Bio's investors include Bain Capital Life Sciences, RA Capital, Sofinnova Ventures, Atlas Venture, Forbion.